Analysis of the course of Parkinson's disease under dopaminergic therapy: Performance of “fast tapping” is not a suitable parameter
Identifieur interne : 003A25 ( Main/Exploration ); précédent : 003A24; suivant : 003A26Analysis of the course of Parkinson's disease under dopaminergic therapy: Performance of “fast tapping” is not a suitable parameter
Auteurs : Peter H. Kraus [Allemagne] ; Peter Klotz [Allemagne] ; Arndt Hoffmann [Allemagne] ; Johannes Lewe [Allemagne] ; Horst Przuntek [Allemagne]Source :
- Movement Disorders [ 0885-3185 ] ; 2005-03.
English descriptors
- KwdEn :
- Bromocriptine (administration & dosage), Bromocriptine (therapeutic use), Cross-Sectional Studies, Disease Progression, Dopamine Agonists (administration & dosage), Dopamine Agonists (therapeutic use), Female, Humans, Levodopa (administration & dosage), Levodopa (therapeutic use), Male, Middle Aged, Parkinson Disease (diagnosis), Parkinson Disease (drug therapy), Parkinson Disease (physiopathology), Parkinson's disease, course, peg board, plugging, tapping, therapy control.
- MESH :
- chemical , administration & dosage : Bromocriptine, Dopamine Agonists, Levodopa.
- chemical , therapeutic use : Bromocriptine, Dopamine Agonists, Levodopa.
- diagnosis : Parkinson Disease.
- drug therapy : Parkinson Disease.
- physiopathology : Parkinson Disease.
- Cross-Sectional Studies, Disease Progression, Female, Humans, Male, Middle Aged.
Abstract
In addition to clinical rating scales, instrumental methods are employed frequently for assessment of performance or motor deficits in Parkinson's disease (PD). Many studies have analyzed such parameters in cross‐sectional studies. We employed a battery of tests to investigate fine motor performance over a period of 4 years in 411 de novo parkinsonian patients from the Prado study. Specifically, tapping and pegboard testing (“plugging”) were evaluated and performance on these tests compared with clinical ratings. Plugging scores correlated well with tapping scores and clinical rating at each assessment timepoint. Both tests also showed significant differences to healthy controls. Nevertheless “fast tapping” was found to be less impaired than was plugging in de novo patients. Over time, it was observed that plugging scores, but not tapping scores, exhibited changes that paralleled movements in clinical score. Plugging scores exhibited a marked response to dopaminergic therapy whereas fast tapping showed no therapeutic response. Fast tapping is certainly not suitable for assessment of bradykinesia or hypokinesia, and does not respond to dopaminergic therapy. © 2004 Movement Disorder Society
Url:
DOI: 10.1002/mds.20265
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Istex, to step Corpus: 001558
- to stream Istex, to step Curation: 001558
- to stream Istex, to step Checkpoint: 002435
- to stream PubMed, to step Corpus: 003190
- to stream PubMed, to step Curation: 003190
- to stream PubMed, to step Checkpoint: 003236
- to stream Ncbi, to step Merge: 001111
- to stream Ncbi, to step Curation: 001111
- to stream Ncbi, to step Checkpoint: 001111
- to stream Main, to step Merge: 005112
- to stream Main, to step Curation: 003A25
Le document en format XML
<record><TEI wicri:istexFullTextTei="biblStruct"><teiHeader><fileDesc><titleStmt><title xml:lang="en">Analysis of the course of Parkinson's disease under dopaminergic therapy: Performance of “fast tapping” is not a suitable parameter</title><author><name sortKey="Kraus, Peter H" sort="Kraus, Peter H" uniqKey="Kraus P" first="Peter H." last="Kraus">Peter H. Kraus</name></author><author><name sortKey="Klotz, Peter" sort="Klotz, Peter" uniqKey="Klotz P" first="Peter" last="Klotz">Peter Klotz</name></author><author><name sortKey="Hoffmann, Arndt" sort="Hoffmann, Arndt" uniqKey="Hoffmann A" first="Arndt" last="Hoffmann">Arndt Hoffmann</name></author><author><name sortKey="Lewe, Johannes" sort="Lewe, Johannes" uniqKey="Lewe J" first="Johannes" last="Lewe">Johannes Lewe</name></author><author><name sortKey="Przuntek, Horst" sort="Przuntek, Horst" uniqKey="Przuntek H" first="Horst" last="Przuntek">Horst Przuntek</name></author></titleStmt><publicationStmt><idno type="wicri:source">ISTEX</idno><idno type="RBID">ISTEX:4DF502B0BFAE1AB3E0DEF87ED235F7AB46E23A73</idno><date when="2005" year="2005">2005</date><idno type="doi">10.1002/mds.20265</idno><idno type="url">https://api.istex.fr/document/4DF502B0BFAE1AB3E0DEF87ED235F7AB46E23A73/fulltext/pdf</idno><idno type="wicri:Area/Istex/Corpus">001558</idno><idno type="wicri:Area/Istex/Curation">001558</idno><idno type="wicri:Area/Istex/Checkpoint">002435</idno><idno type="wicri:doubleKey">0885-3185:2005:Kraus P:analysis:of:the</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:15584027</idno><idno type="wicri:Area/PubMed/Corpus">003190</idno><idno type="wicri:Area/PubMed/Curation">003190</idno><idno type="wicri:Area/PubMed/Checkpoint">003236</idno><idno type="wicri:Area/Ncbi/Merge">001111</idno><idno type="wicri:Area/Ncbi/Curation">001111</idno><idno type="wicri:Area/Ncbi/Checkpoint">001111</idno><idno type="wicri:doubleKey">0885-3185:2005:Kraus P:analysis:of:the</idno><idno type="wicri:Area/Main/Merge">005112</idno><idno type="wicri:Area/Main/Curation">003A25</idno><idno type="wicri:Area/Main/Exploration">003A25</idno></publicationStmt><sourceDesc><biblStruct><analytic><title level="a" type="main" xml:lang="en">Analysis of the course of Parkinson's disease under dopaminergic therapy: Performance of “fast tapping” is not a suitable parameter</title><author><name sortKey="Kraus, Peter H" sort="Kraus, Peter H" uniqKey="Kraus P" first="Peter H." last="Kraus">Peter H. Kraus</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Ruhr‐University Bochum, Department of Neurology, St. Josef‐Hospital, Bochum</wicri:regionArea><wicri:noRegion>Bochum</wicri:noRegion><wicri:noRegion>Bochum</wicri:noRegion></affiliation></author><author><name sortKey="Klotz, Peter" sort="Klotz, Peter" uniqKey="Klotz P" first="Peter" last="Klotz">Peter Klotz</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Ruhr‐University Bochum, Department of Neurology, St. Josef‐Hospital, Bochum</wicri:regionArea><wicri:noRegion>Bochum</wicri:noRegion><wicri:noRegion>Bochum</wicri:noRegion></affiliation></author><author><name sortKey="Hoffmann, Arndt" sort="Hoffmann, Arndt" uniqKey="Hoffmann A" first="Arndt" last="Hoffmann">Arndt Hoffmann</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Ruhr‐University Bochum, Department of Neurology, St. Josef‐Hospital, Bochum</wicri:regionArea><wicri:noRegion>Bochum</wicri:noRegion><wicri:noRegion>Bochum</wicri:noRegion></affiliation></author><author><name sortKey="Lewe, Johannes" sort="Lewe, Johannes" uniqKey="Lewe J" first="Johannes" last="Lewe">Johannes Lewe</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Ruhr‐University Bochum, Department of Neurology, St. Josef‐Hospital, Bochum</wicri:regionArea><wicri:noRegion>Bochum</wicri:noRegion><wicri:noRegion>Bochum</wicri:noRegion></affiliation></author><author><name sortKey="Przuntek, Horst" sort="Przuntek, Horst" uniqKey="Przuntek H" first="Horst" last="Przuntek">Horst Przuntek</name><affiliation wicri:level="1"><country xml:lang="fr">Allemagne</country><wicri:regionArea>Ruhr‐University Bochum, Department of Neurology, St. Josef‐Hospital, Bochum</wicri:regionArea><wicri:noRegion>Bochum</wicri:noRegion><wicri:noRegion>Bochum</wicri:noRegion></affiliation></author></analytic><monogr></monogr><series><title level="j">Movement Disorders</title><title level="j" type="abbrev">Mov. Disord.</title><idno type="ISSN">0885-3185</idno><idno type="eISSN">1531-8257</idno><imprint><publisher>Wiley Subscription Services, Inc., A Wiley Company</publisher><pubPlace>Hoboken</pubPlace><date type="published" when="2005-03">2005-03</date><biblScope unit="vol">20</biblScope><biblScope unit="issue">3</biblScope><biblScope unit="page" from="348">348</biblScope><biblScope unit="page" to="354">354</biblScope></imprint><idno type="ISSN">0885-3185</idno></series><idno type="istex">4DF502B0BFAE1AB3E0DEF87ED235F7AB46E23A73</idno><idno type="DOI">10.1002/mds.20265</idno><idno type="ArticleID">MDS20265</idno></biblStruct></sourceDesc><seriesStmt><idno type="ISSN">0885-3185</idno></seriesStmt></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Bromocriptine (administration & dosage)</term><term>Bromocriptine (therapeutic use)</term><term>Cross-Sectional Studies</term><term>Disease Progression</term><term>Dopamine Agonists (administration & dosage)</term><term>Dopamine Agonists (therapeutic use)</term><term>Female</term><term>Humans</term><term>Levodopa (administration & dosage)</term><term>Levodopa (therapeutic use)</term><term>Male</term><term>Middle Aged</term><term>Parkinson Disease (diagnosis)</term><term>Parkinson Disease (drug therapy)</term><term>Parkinson Disease (physiopathology)</term><term>Parkinson's disease</term><term>course</term><term>peg board</term><term>plugging</term><term>tapping</term><term>therapy control</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Bromocriptine</term><term>Dopamine Agonists</term><term>Levodopa</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Bromocriptine</term><term>Dopamine Agonists</term><term>Levodopa</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" qualifier="physiopathology" xml:lang="en"><term>Parkinson Disease</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Cross-Sectional Studies</term><term>Disease Progression</term><term>Female</term><term>Humans</term><term>Male</term><term>Middle Aged</term></keywords></textClass><langUsage><language ident="en">en</language></langUsage></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">In addition to clinical rating scales, instrumental methods are employed frequently for assessment of performance or motor deficits in Parkinson's disease (PD). Many studies have analyzed such parameters in cross‐sectional studies. We employed a battery of tests to investigate fine motor performance over a period of 4 years in 411 de novo parkinsonian patients from the Prado study. Specifically, tapping and pegboard testing (“plugging”) were evaluated and performance on these tests compared with clinical ratings. Plugging scores correlated well with tapping scores and clinical rating at each assessment timepoint. Both tests also showed significant differences to healthy controls. Nevertheless “fast tapping” was found to be less impaired than was plugging in de novo patients. Over time, it was observed that plugging scores, but not tapping scores, exhibited changes that paralleled movements in clinical score. Plugging scores exhibited a marked response to dopaminergic therapy whereas fast tapping showed no therapeutic response. Fast tapping is certainly not suitable for assessment of bradykinesia or hypokinesia, and does not respond to dopaminergic therapy. © 2004 Movement Disorder Society</div></front></TEI><affiliations><list><country><li>Allemagne</li></country></list><tree><country name="Allemagne"><noRegion><name sortKey="Kraus, Peter H" sort="Kraus, Peter H" uniqKey="Kraus P" first="Peter H." last="Kraus">Peter H. Kraus</name></noRegion><name sortKey="Hoffmann, Arndt" sort="Hoffmann, Arndt" uniqKey="Hoffmann A" first="Arndt" last="Hoffmann">Arndt Hoffmann</name><name sortKey="Klotz, Peter" sort="Klotz, Peter" uniqKey="Klotz P" first="Peter" last="Klotz">Peter Klotz</name><name sortKey="Lewe, Johannes" sort="Lewe, Johannes" uniqKey="Lewe J" first="Johannes" last="Lewe">Johannes Lewe</name><name sortKey="Przuntek, Horst" sort="Przuntek, Horst" uniqKey="Przuntek H" first="Horst" last="Przuntek">Horst Przuntek</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003A25 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003A25 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Santé
|area= MovDisordV3
|flux= Main
|étape= Exploration
|type= RBID
|clé= ISTEX:4DF502B0BFAE1AB3E0DEF87ED235F7AB46E23A73
|texte= Analysis of the course of Parkinson's disease under dopaminergic therapy: Performance of “fast tapping” is not a suitable parameter
}}
| This area was generated with Dilib version V0.6.23. |  |